Sanara Medtech Stock Forward View - Simple Exponential Smoothing
| SMTI Stock | USD 20.55 1.50 6.80% |
Sanara Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Sanara Medtech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 5th of February 2026 the relative strength index (rsi) of Sanara Medtech's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (1.56) | EPS Estimate Next Year 0.475 | Wall Street Target Price 40 | EPS Estimate Current Quarter (0.21) |
Using Sanara Medtech hype-based prediction, you can estimate the value of Sanara Medtech from the perspective of Sanara Medtech response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Sanara Medtech on the next trading day is expected to be 20.55 with a mean absolute deviation of 0.70 and the sum of the absolute errors of 42.24. Sanara Medtech after-hype prediction price | USD 20.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections. Sanara Medtech Additional Predictive Modules
Most predictive techniques to examine Sanara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sanara using various technical indicators. When you analyze Sanara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sanara Medtech Simple Exponential Smoothing Price Forecast For the 6th of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Sanara Medtech on the next trading day is expected to be 20.55 with a mean absolute deviation of 0.70, mean absolute percentage error of 1.39, and the sum of the absolute errors of 42.24.Please note that although there have been many attempts to predict Sanara Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sanara Medtech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sanara Medtech Stock Forecast Pattern
| Backtest Sanara Medtech | Sanara Medtech Price Prediction | Research Analysis |
Sanara Medtech Forecasted Value
In the context of forecasting Sanara Medtech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sanara Medtech's downside and upside margins for the forecasting period are 15.81 and 25.29, respectively. We have considered Sanara Medtech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Sanara Medtech stock data series using in forecasting. Note that when a statistical model is used to represent Sanara Medtech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.6019 |
| Bias | Arithmetic mean of the errors | 0.122 |
| MAD | Mean absolute deviation | 0.704 |
| MAPE | Mean absolute percentage error | 0.0316 |
| SAE | Sum of the absolute errors | 42.24 |
Predictive Modules for Sanara Medtech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sanara Medtech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sanara Medtech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sanara Medtech After-Hype Price Density Analysis
As far as predicting the price of Sanara Medtech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sanara Medtech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sanara Medtech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sanara Medtech Estimiated After-Hype Price Volatility
In the context of predicting Sanara Medtech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sanara Medtech's historical news coverage. Sanara Medtech's after-hype downside and upside margins for the prediction period are 15.60 and 25.08, respectively. We have considered Sanara Medtech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sanara Medtech is not too volatile at this time. Analysis and calculation of next after-hype price of Sanara Medtech is based on 3 months time horizon.
Sanara Medtech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sanara Medtech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanara Medtech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sanara Medtech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.38 | 4.74 | 0.21 | 0.02 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
20.55 | 20.34 | 1.02 |
|
Sanara Medtech Hype Timeline
Sanara Medtech is at this time traded for 20.55. The entity has historical hype elasticity of -0.21, and average elasticity to hype of competition of -0.02. Sanara is anticipated to decline in value after the next headline, with the price expected to drop to 20.34. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.02%, whereas the daily expected return is at this time at -0.38%. The volatility of related hype on Sanara Medtech is about 11285.71%, with the expected price after the next announcement by competition of 20.53. About 65.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.72. Sanara Medtech last dividend was issued on the 10th of May 2019. The entity had 1:100 split on the 10th of May 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections.Sanara Medtech Related Hype Analysis
Having access to credible news sources related to Sanara Medtech's direct competition is more important than ever and may enhance your ability to predict Sanara Medtech's future price movements. Getting to know how Sanara Medtech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sanara Medtech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STXS | Stereotaxis | 0.01 | 9 per month | 0.00 | (0.12) | 4.69 | (6.43) | 18.81 | |
| XGN | Exagen Inc | 0.15 | 6 per month | 0.00 | (0.52) | 3.11 | (6.84) | 17.46 | |
| NEO | NeoGenomics | (0.77) | 11 per month | 2.00 | 0.10 | 4.99 | (3.84) | 13.39 | |
| LFMD | LifeMD Inc | (0.41) | 7 per month | 0.00 | (0.18) | 8.13 | (7.02) | 28.11 | |
| HITI | High Tide | (0.09) | 8 per month | 0.00 | (0.14) | 4.78 | (4.50) | 19.26 | |
| SGHT | Sight Sciences | 0.17 | 10 per month | 3.50 | 0.09 | 9.34 | (6.23) | 25.08 | |
| TBRG | TruBridge | (0.08) | 8 per month | 1.99 | 0.07 | 3.63 | (3.04) | 9.75 | |
| OMI | Owens Minor | 0.26 | 5 per month | 0.00 | (0.19) | 8.94 | (13.10) | 27.99 | |
| TRDA | Entrada Therapeutics | 0.32 | 4 per month | 2.38 | 0.19 | 6.65 | (4.00) | 15.00 | |
| VMD | Viemed Healthcare | 0.02 | 9 per month | 1.16 | 0.17 | 3.57 | (2.64) | 8.29 |
Other Forecasting Options for Sanara Medtech
For every potential investor in Sanara, whether a beginner or expert, Sanara Medtech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sanara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sanara. Basic forecasting techniques help filter out the noise by identifying Sanara Medtech's price trends.Sanara Medtech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sanara Medtech Market Strength Events
Market strength indicators help investors to evaluate how Sanara Medtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sanara Medtech shares will generate the highest return on investment. By undertsting and applying Sanara Medtech stock market strength indicators, traders can identify Sanara Medtech entry and exit signals to maximize returns.
Sanara Medtech Risk Indicators
The analysis of Sanara Medtech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sanara Medtech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sanara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.88 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sanara Medtech
The number of cover stories for Sanara Medtech depends on current market conditions and Sanara Medtech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sanara Medtech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sanara Medtech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sanara Medtech Short Properties
Sanara Medtech's future price predictability will typically decrease when Sanara Medtech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sanara Medtech often depends not only on the future outlook of the potential Sanara Medtech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sanara Medtech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.5 M | |
| Cash And Short Term Investments | 15.9 M |
Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is there potential for Health Care Equipment & Supplies market expansion? Will Sanara introduce new products? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sanara Medtech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.